DOCSLIB.ORG

2018Almubark10454247phd.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

University of Plymouth PEARL https://pearl.plymouth.ac.uk 04 University of Plymouth Research Theses 01 Research Theses Main Collection 2018 ASSESSING COGNITIVE FUNCTIONS IN ARABIC AND ENGLISH SPEAKING POPULATIONS Almubark, Bazah http://hdl.handle.net/10026.1/11119 University of Plymouth All content in PEARL is protected by copyright law. Author manuscripts are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author. This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognise that its copyright rests with its author and that no quotation from the thesis and no information derived from it may be published without the author's prior consent. 1 ASSESSING COGNITIVE FUNCTIONS IN ARABIC AND ENGLISH SPEAKING POPULATIONS by BAZAH MAJED ALMUBARK A thesis submitted to Plymouth University in partial fulfilment of the degree of DOCTOR OF PHILOSOPHY School of Psychology Faculty of Health and Human Sciences March 2018 2 Acknowledgment I would like to express my deepest appreciation and sincere gratitude to my director of studies Dr. Caroline Floccia, who supported me throughout my PhD study. She continually provided me with supervision and help required for my PhD study and related researches. I am extremely lucky to have her as my director of studies and mentor. Without her guidance and persistent help this thesis would not have been possible. I would also like to thank Dr. Allegra Cattani for her valuable advice and help through my PhD study together with Prof. Tim Hollins for his help with the second study. A thank you to Dr. Ahmed Megreya who helped with the stimuli used in the third study. In addition, a thank you to the participants who took part in all my PhD researches. Finally, a special thank you to my mother and the love of my life 'Sultanah Al Saud' without her blessings and support I would not have achieved what I achieved today. Besides, a special thank you to my father 'Majed Almubark' who recently passed away. I wish he was still with me and celebrate the completion my PhD study. I love you dad and God bless your soul. I dedicate all the efforts and thoughts in this thesis to my beloved parents. 3 Author’s declaration At no time during the registration for the degree of Doctor of Philosophy has the author been registered for any other University award without prior agreement of the Graduate Sub-Committee. Work submitted for this research degree at the Plymouth University has not formed part of any other degree either at Plymouth University or at another establishment. All the studies carried out in this thesis were conducted by myself, including literature review, developing tools, selecting of stimuli, designing of experiments, data collection, analysis, and discussion of results. Publications: Almubark, B., Cattani, A., Floccia, C., (submitted). Translation, cultural adaptation and validation of the Cognistat for its use in Arabic-speaking population with acquired brain injury. Almubark, B., Cattani, A., Perfict, T., Floccia, C., (submitted). Development and validation of the Plymouth Saudi Memory Test (PSMT) for Arabic-speaking population with acquired brain injury. Presentation and conference attended: Almubark, B., Floccia, C., Cattani A., & Slade A. (2015). Assessment of cognitive function in Arabic speaking population. Poster presented at the 8th Saudi Student Conference, London, UK, February. 4 Almubark, B., Floccia, C., Cattani A., & Slade A. (2015). Assessment of cognitive function in Arabic speaking population. Poster presented at the Research in Rehabilitation Winter Meeting, Manchester, UK, February. Almubark, B., Floccia, C., Cattani A., & Slade A. (2015). Assessment of cognitive function in Arabic speaking population with stroke: A pilot study. Poster presented at the 24th European Stroke Conference, Vienna, Austria, May. Almubark, B., Floccia, C., Cattani A., & Slade A. (2015). Assessment of cognitive function in Arabic speaking population. Poster presented at the 9th World Congress of the International Society of Physical and Rehabilitation Medicine, Berlin, Germany, June. Almubark, B., Cattani A., & Floccia C. (2017). Translation, cultural adaptation and validation of the Cognistat for its use with Arabic speaking population with Acquired Brain Injury. Official launching of the Arabic Cognistat at the Arab health exhibition and congress, Dubia, UAE, January. Almubark, B., Cattani A., Hollins T., & Floccia C. (2017). Development and validation of the Long Term Memory Test (LTMT) for the Arabic speaking population with acquired brain injury. Poster presented at the 14th Congress of the European Forum for Research in Rehabilitation, Glasgow, UK, May. Almubark, B., Cattani A., & Floccia C. (2017). Translation, cultural adaptation and validation of the Cognistat for its use with Arabic speaking population with Acquired Brain Injury. Poster presented at the 14th Congress of the European Forum for Research in Rehabilitation, Glasgow, UK, May. 5 Word count of main body of thesis: 41 779 Signed…………………………………… Date……………………………………… 6 Bazah Majed Almubark Assessing cognitive functions in Arabic and English speaking populations Abstract The aims of this thesis are to assess cognitive functions in adult Arabic populations for clinical purposes, and to examine resulting cultural differences between Arabic and English speaking populations. In the first study, we translated, culturally adapted and validated an existing cognitive screening tool (Cognistat) for its use with Arabic adults with Acquired Brain Injury (ABI), and we examined the differences in cognitive performance between Arabic and English individuals. A total of 107 healthy Arabic speaking adults and 62 ABI patients (30 stroke and 32 traumatic brain injury; TBI) between 18-60 years were involved in the study. The results indicated that the translated/adapted tool is valid and reliable for its use with Arabic individuals with ABI. Cultural differences between Arabic and English individuals were found in orientation to time, memory, language (repetition and naming), construction, calculation and reasoning (similarities and judgment). In the second study we developed and validated a memory test – the Plymouth Saudi Memory Test (PSMT) – that assesses a wide range of memory domains in Arabic adults with ABI; cultural variations in memory functioning between both Arabic and English individuals were also investigated. A total of 80 healthy Arabic speaking adults and 61 ABI patients (30 stroke and 31 TBI) between 18-60 years were tested. The results demonstrated that the PSMT is a valid and reliable test for detecting memory deficits among Arabic adults with ABI, and the comparison between the 7 Arabic and English individuals revealed variations in working memory, semantic memory, and prospective memory. As a follow-up of cultural differences uncovered in the first two studies, the third and final study investigated the effect of length of stay in the UK on unfamiliar faces recognition, as well as cultural differences in unfamiliar faces recognition between Arabic and British individuals. A face recognition task that involved both Arabic and English faces was designed, and 35 participants (19 Arabs and 16 English) between 18-49 were tested. Typically, Westerners show an external feature advantage when processing unfamiliar faces, while participants from Arabic countries show a greater reliance on internal features. Results showed that the expected internal feature advantage in Arabic participants is more likely to be found for those Arabic immigrants who spend more time back in their home country, suggesting that visual processing biases can be modified with exposure in adulthood. Altogether, these results provide the clinical and research community with new tools to evaluate cognitive skills in Arabic-speaking adults, and add to the body of evidence that some of these skills can be shaped by cultural experience. The findings of the cultural differences further our understanding of the potential variations in cognitive functions among people from different cultural backgrounds. 8 List of Contents Acknowledgment .................................................................................................................................. 3 Author’s declaration ............................................................................................................................. 4 Abstract .................................................................................................................................................. 7 General introduction........................................................................................................................... 17 Chapter 1: Translation, cultural adaptation and validation of the Cognistat ................. 20 Introduction .......................................................................................................................................... 20 Literature review ................................................................................................................................. 22 Cultural differences in perception and cognition ....................................................................... 22 Attention ......................................................................................................................................
Recommended publications
  • Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the Early Diagnosis of Dementia Across a Variety of Healthcare Settings (Protocol)

    Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the Early Diagnosis of Dementia Across a Variety of Healthcare Settings (Protocol)

    Cochrane Database of Systematic Reviews Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings (Protocol) Lees RA, Stott DJ, McShane R, Noel-Storr AH, Quinn TJ Lees RA, Stott DJ, McShane R, Noel-Storr AH, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings. Cochrane Database of Systematic Reviews 2014, Issue 10. Art. No.: CD011333. DOI: 10.1002/14651858.CD011333. www.cochranelibrary.com Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings (Protocol) Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 BACKGROUND .................................... 1 OBJECTIVES ..................................... 4 METHODS ...................................... 4 REFERENCES ..................................... 7 APPENDICES ..................................... 8 DECLARATIONSOFINTEREST . 19 Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of i healthcare settings (Protocol) Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. [Diagnostic Test Accuracy Protocol] Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)
  • Lightning Review of Neuropsychological Assessments

    Lightning Review of Neuropsychological Assessments

    Lightning Review of Neuropsychological Assessments Lightning Review of Neuropsychological Assessments Geared To Psychiatry Board Exam Preparation By Jack Krasuski, MD 877-225-8384 1 of 23 www.masterpsych.com Lightning Review of Neuropsychological Assessments Table of Contents Psychological Testing Overview Wechsler Adult Intelligence Scale Wechsler Intelligence Scale for Children Wechsler Preschool & Performance Scale of Intelligence Leiter International Performance Scale Bayley Scales of Infant and Toddler Development Wechsler Memory Scale Auditory Verbal Learning Test California Verbal Learning Test Hopkins Verbal Learning Test Peabody Picture Vocabulary Test Boston Diagnostic Aphasia Examination Western Aphasia Battery Stroop Color & Word Test Wisconsin Card Sorting Test Connors Continuous Performance Test Test of Variables of Attention Wechsler Individual Achievement Test Peabody Individual Achievement Test Halstead Reitan Neuropsychological Battery Luria Nebraska Neuropsychological Battery Minnesota Multiphasic Personality Inventory Thematic Apperception Test (TAT) 877-225-8384 2 of 23 www.masterpsych.com Lightning Review of Neuropsychological Assessments Notices Copyright Notice Copyright © 2009-2018 American Physician Institute for Advanced Professional Studies, LLC. All rights reserved. This manuscript may not be transmitted, copied, reprinted, in whole or in part, without the express written permission of the copyright holder. Requests for permission or further information should be addressed to Jack Krasuski at: [email protected] or American Physician Institute for Advanced Professional Studies LLC, 900 Oakmont Ln., Suite 450, Westmont, IL 60559 Disclaimer Notice This publication is designed to provide general educational advice. It is provided to the reader with the understanding that Jack Krasuski and American Physician Institute for Advanced Professional Studies LLC are not rendering medical services and are not affiliated with the American Board of Psychiatry and Neurology.
  • Teleneuropsychology (Telenp) in Response to COVID-19: Practical Guidelines to Balancing Validity Concerns with Clinical Need

    Teleneuropsychology (Telenp) in Response to COVID-19: Practical Guidelines to Balancing Validity Concerns with Clinical Need

    Teleneuropsychology (TeleNP) in Response to COVID-19: Practical Guidelines to Balancing Validity Concerns with Clinical Need Rene Stolwyk, DPsych(Clin.Neuro), PsyBA Dustin B. Hammers, Ph.D., ABPP(CN) Senior Lecturer and Clinical Neuropsychologist Board Certified in Clinical Neuropsychology Turner Institute for Brain and Mental Health Associate Professor, Department of Neurology Monash University, Melbourne, Australia University of Utah, Salt Lake City, Utah Email: [email protected] Email: [email protected] Twitter: @rene_stolwyk Lana Harder, PhD, ABPP C. Munro Cullum, Ph.D., ABPP-CN Board Certified in Clinical Neuropsychology Professor of Psychiatry, Neurology, and Neurosurgery Board Certified Subspecialist in Pediatric Neuropsychology Pam Blumenthal Distinguished Professor of Clinical Psychology Children’s Medical Center Dallas Senior Neuropsychologist, O’Donnell Brain Institute Associate Professor of Psychiatry and Neurology University of Texas Southwestern Medical Center University of Texas Southwestern Medical Center Email: [email protected] Email: [email protected] INS Webinar Presented on 4/2/2020 Objectives Following this webinar, attendees will be able to: • Understand the evidence base supporting TeleNP procedures as well as the strengths and limitations of different models • Apply knowledge of models of TeleNP and evaluate potential feasibility within your own clinical settings • Understand key legal and ethical considerations when providing TeleNP services Outline • Ethical and Legal Challenges • Logistical and Practical Considerations • Models of TeleNP • Evidence for use of Specific Measures over TeleNP and Patient Satisfaction • Practical Considerations for Home-Based TeleNP Our Experience with TeleNP • Dr. Hammers leads the University of Utah TeleNP Program • Joint relationship between University of Utah Cognitive Disorders Clinic and St.
  • (MCI) and Dementias in Your Clinical Practice

    (MCI) and Dementias in Your Clinical Practice

    6/6/18 Assessment, Identification, and Management of Mild Cognitive Impairment (MCI) and Dementias in Your Clinical Practice Mark Hogue, Psy.D. Donald McAleer, Psy.D., ABPP Northshore Neurosciences Overview • MCI • Definitions, Subtypes, Screening/ assessment • Dementias • Definitions, Subtypes, Screening / Assessment • Management of Cognitive issues for the general clinician • Referrals/ treatments • Family • Legal / Driving 1 6/6/18 Erie Times-News June 3, 2018 Dementia and Mild Cognitive Impairment • Globally, the number of people diagnosed with dementia is increasing every year at an alarming rate. There are currently over 46.8 million people living with dementia and this is estimated to rise to 131.5 million people by 2050. (Tozer, 7/5/17) • Dementia • A loss of cognitive processes from a prior level of cognitive processes, as compared to age-mates, and due to a pathophysiological process. • MCI • An intermediate step between normal cognition and dementia • A measurable deficit in at least one domain, absent dementia and showing no appreciable deficit in ADL functioning 2 6/6/18 Mild Cognitive Impairment • Diagnos(c concepts to describe cogni(ve change in aging • Benign senescent forge-ulness (BSF) – Kral, 1962 • Mild Cogni?ve Impairment (MCI) – Reisberg et al., 1982 • Age-Associated Memory Impairment (AAMI) – CooK et al., 1986 • Late-life forge-ulness (LLF) – BlacKford & La Rue, 1989 • Age-Associated Cogni?ve Decline (AACD) – Levy et al., 1994 • Cogni?ve Impairment No Demen?a (CIND) – Graham et al., 1997 • Amnes?c Mild Cogni?ve
  • List of Psychological Tests Material Was Prepared for Use As an Aid in Handling Requests for Psychological Testing

    List of Psychological Tests Material Was Prepared for Use As an Aid in Handling Requests for Psychological Testing

    List of Psychological Tests Material was prepared for use as an aid in handling requests for psychological testing. The minutes allocated for each test include administration, scoring and write up. Determination of the medical necessity of psychological tests always requires consideration of the clinical facts of the specific case to assure that tests given are a cost-effective means of determining the appropriate treatment for the individual patient and are related to the diagnosis and treatment of covered mental health conditions. INSTRUMENT TYPE AGE MINUT COMMENTS ES 16 Personality Factor Questionnaire (16-PF) Personality 16+ 30 35-60 min per Tests in Print for admin time only ABEL Screen Sexual Interest Adol + 120 Primarily forensic in nature: may not be covered Achenbach System of Empirically Based Assessment 60 Preschool Module Behav Rating Scale 1.5-5 10 Caregiver-Teacher Report Form Behav Rating Scale 1.5-5 10 Child Behavior Checklist (CBCL) Behav Rating Scale 1.5-5 15 Teacher Report Form Behav Rating Scale 6-18 20 Youth Self-Report (YSR) Behav Rating Scale 11-18 20 ACTeERS-ADD-H Comprehensive, Teachers Rating Scale Behav Rating Scale 5 – 13 15 Adaptive Behavior Assessment System (ABAS II) Behav Rating Scale 0-89 30 Adaptive Behavior Scale (ABS) Developmental 3-18 30 ADHD Rating Scale Behav Rating Scale 4 – 18 15 Adolescent Anger Rating Scale Behav Rating Scale 11-19 15 Adolescent Apperception Cards Projective Personality 12 – 19 60 Adult Behavior Checklist (ABCL) Behav Rating Scale 18-89 30 Admin. Time 20 min. + 10 min. for scoring, interpretation, write up. Adolescent Psychopathology Scale Personality Child-adult 60 Alzheimer’s Quick Test (AQT) Neuro Adult 10 Amen System Checklist Behav Rating Scale Adult 15 Animal Naming Neuro Child-adult 10 Aphasia Screening Test (Reitan Indiana) Neuro 5+ 30 Asperger’s Syndrome Diagnostic Scales (ASDS) Rating scale 5-18 20 Attention Deficit Disorder Eval.
  • Rehabilitation Information Pack a Range of Products from Pearson Assessment for Professionals Working in the Area of Rehabilitation

    Rehabilitation Information Pack a Range of Products from Pearson Assessment for Professionals Working in the Area of Rehabilitation

    Rehabilitation Information Pack A range of products from Pearson Assessment for professionals working in the area of rehabilitation The Functional UK Administration and Scoring Manual TFL S Living Scale UK Edition Examiner’s Manual C. Munro Cullum Myron F. Weiner Kathleen C. Saine www.pearsonclinical.co.uk Welcome... Introducing our 2013 Rehabilitation Information Pack Dear Colleague, Pearson (Assessment) is one of the UK’s leading publishers of standardised assessments. Our tests are used by a number of professionals in both health and education settings and we strive to develop and distribute tools that are timely and in line with good practice guidelines. For example, we are mindful of targets set by the Department of Health, for the early recognition of debilitating neurological and cognitive disorders including dementia and the aim for ‘two-thirds of people with dementia [to be] identified and given appropriate support by 2015’. In this pack you will find a range of products that can aid you inidentifying cognitive impairments and assist you in the evaluation of your clients; helping you to plan intervention strategies and enhance your evidence- based practice. Among these assessments is the new Brief Cognitive Status Exam (BCSE) which is designed to assess a client’s cognitive ability quickly and reliably, and the RBANS™ - Update which can be used as a stand-alone “core” battery for the detection and characterization of dementia in the elderly. Together with early diagnosis, assessment of activities of daily living can be vital in assisting service users maintain independence or return to everyday life. The UK-normed Rivermead Behavioural Memory Test- Third Edition, Rookwood Driving Battery and The Functional Living Scales – UK Version all have excellent ecological validity which places assessment in real life context; making the results more meaningful to you as a professional, and your clients.
  • Geriatric Performance on an Abbreviated Version of the Boston Naming Test

    Geriatric Performance on an Abbreviated Version of the Boston Naming Test

    Applied Neuropsychology Copyright # 2007 by 2007, Vol. 14, No. 3, 215–223 Lawrence Erlbaum Associates, Inc. Geriatric Performance on an Abbreviated Version of the Boston Naming Test Angela L. Jefferson Alzheimer’s Disease Center & Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA Sarah Wong and Talia S. Gracer Alzheimer’s Disease Center & Department of Neurology, Boston University School of Medicine, Boston, MA and Department of Psychology, Tufts University, Medford, Massachusetts, USA Al Ozonoff Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA Robert C. Green Alzheimer’s Disease Center & Department of Neurology, Boston University School of Medicine, Boston, MA and Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA Robert A. Stern Alzheimer’s Disease Center & Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA Abbreviated neuropsychological protocols are increasingly utilized secondary to time- constraints within research and healthcare settings, yet normative data for these abbrevi- ated instruments are lacking. We present geriatric performances and normative data for the Boston Naming Test 30-item even version (BNT-30). Data were utilized from the BU-ADCC registry (n ¼ 441, ages 55–98) and included 219 normal controls (NC), 155 participants with mild cognitive impairment (MCI), and 67 participants with Alzheimer’s disease (AD). The NC group (M ¼ 28.7, SD ¼ 1.8) significantly outperformed both MCI (M ¼ 26.2, SD ¼ 4.4) and AD (M ¼ 22.1, SD ¼ 4.8) groups, and the MCI group outperformed the AD group. Normative data generated for the NC participants revealed a significant between-group difference for sex (males M ¼ 29.1, SD ¼ 1.7; females M ¼ 28.4, SD ¼ 1.8) and race (White M ¼ 28.8, SD ¼ 1.7; African American M ¼ 27.5, SD ¼ 2.1).
  • Frontotemporal Dementia, Semantic Dementia, and Alzheimer’S Disease: the Contribution of Standard Neuropsychological Tests to Differential Diagnosis

    Frontotemporal Dementia, Semantic Dementia, and Alzheimer’S Disease: the Contribution of Standard Neuropsychological Tests to Differential Diagnosis

    Frontotemporal Dementia, Semantic Dementia, and Alzheimer’s Disease: The Contribution of Standard Neuropsychological Tests to Differential Diagnosis J. Diehl, MD, A.U. Monsch, PhD, C. Aebi, PhD, S. Wagenpfeil, PhD, S. Krapp, T. Grimmer, MD, W. Seeley, MD, H. Förstl, MD, and A. Kurz, MD ABSTRACT CERAD-NAB (Consortium to Establish a Registry for Alzheimer’s Disease–Neuropsychological Assessment Battery) data were compared between 51 patients with frontotemporal dementia, 13 with semantic dementia, and 69 with Alzheimer’s disease. There were statistically significant differences between the 3 groups. Compared with patients with Alzheimer’s disease, patients with frontotemporal dementia were more impaired on Animal Fluency but not on any other CERAD-NAB subtest. Patients with semantic dementia performed worse in Animal Fluency and Boston Naming Test compared with frontotemporal dementia and Alzheimer’s disease. Multiple logistic regression analysis revealed that in the differentiation between frontotemporal dementia and Alzheimer’s disease, the combination of Animal Fluency and Boston Naming Test correctly classified 90.5% of patients. In segregating semantic dementia and Alzheimer’s dis- ease, the combination of Boston Naming Test and Mini Mental State Examination resulted in a correct classification of 96.3%. These findings demonstrate that the Mini Mental State Examination and the language subtests of the CERAD- NAB are valuable clinical instruments for the differential diagnosis between early frontotemporal dementia, semantic dementia, and Alzheimer’s disease. (J Geriatr Psychiatry Neurol 2005; 18: 39–44) Keywords: frontotemporal dementia; semantic dementia; differential diagnosis; CERAD-NAB; Boston Naming test; animal fluency Frontotemporal dementia (FTD) semantic dementia (SD), Received March 1, 2004.
  • Comparing Methods to Evaluate Cognitive Deficits in Commercial Airline Pilots

    Comparing Methods to Evaluate Cognitive Deficits in Commercial Airline Pilots

    Comparing Methods to Evaluate Cognitive Deficits in Commercial Airline Pilots Joshua Potocko, MD/MPH UCSF Occupational and Environmental Medicine Residency 30 Min Background Philosophy Scope Comparisons Evidence Review: Example Questions for the Group BACKGROUND LCDR Joshua R. Potocko, MC (FS/FMF), USN “The views expressed in this presentation reflect the results of research conducted by the author and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the United States Government.” Potocko’s 6 Proclamations: Certain baseline cognitive functions decline with age. Within an individual, these declines are difficult to predict. Between individuals, different types of decline are variable. Understanding the following are critically important to aviation safety: Age-related declines Temporary disturbances in cognitive function, Stable (or progressive) baseline disturbances due to injury, illness, disease, medication, and substance use. When does cognitive dysfunction become unsafe? Cognitive Function Typical, Normal, Adequate, Average Cognitive Inefficiency Circadian, Fatigue, Mood, Stress Cognitive Deficiency Injury, Illness, Meds, Substances Cognitive Disability Above plus regulatory decisions => requires safety factor Baseline New Baseline Unfit Period Injury Illness Meds Baseline Progressive Decline Age XX? Permanently Unfit Disease? PHILOSOPHY Research Question: What is the “best” way to evaluate cognitive deficits in airline pilots? Best: historical? expert opinion?...or
  • Test Selection Process of a Neuropsychological Assessment

    Test Selection Process of a Neuropsychological Assessment

    Test selection Process of a neuropsychological assessment • Review of information provided by referrer and if possible review of medical records Gather • Interview with client and his/her relative or carer information • Purpose of assessment? • Screening test? • Which measure is appropriate for my client? Test selection • Fixed vs flexible battery • Awareness of standardisation procedures Test • Awareness of scoring principles administration and scoring What do you need to consider when selecting a test? ´ Practical considerations ´ How long will it take to administer? ´ What is the time available to assess? What is the patient’s tolerance for testing? ´ Do I have access to the test I want to use? ´ Is it sensitive enough to detect my client’s problems ´ Are there problems which make it practically difficult to administer the test? (e.g., sensory and motor problems) ´ Has testing been completed previously? ´ Are parallel forms available to allow comparison of performance over time? ´ Am I qualified to use the test? Balance between undertaking an adequate assessment and over assessing. Comprehensive Neuropsychological Cognitive Screening Tests Batteries • Potential uses • Potential uses • Early identification of individuals at • Determination of presence and magnitude potential risk for condition or disorder of impairment • May indicate need for further evaluation or • Determination of diagnoses intervention • Determination of functional status, abilities, • May be used to monitor progression of and capacities symptoms or response to intervention
  • Insert Title of Research Report

    Insert Title of Research Report

    ARCHIVED - Archiving Content ARCHIVÉE - Contenu archivé Archived Content Contenu archivé Information identified as archived is provided for L’information dont il est indiqué qu’elle est archivée reference, research or recordkeeping purposes. It est fournie à des fins de référence, de recherche is not subject to the Government of Canada Web ou de tenue de documents. Elle n’est pas Standards and has not been altered or updated assujettie aux normes Web du gouvernement du since it was archived. Please contact us to request Canada et elle n’a pas été modifiée ou mise à jour a format other than those available. depuis son archivage. Pour obtenir cette information dans un autre format, veuillez communiquer avec nous. This document is archival in nature and is intended Le présent document a une valeur archivistique et for those who wish to consult archival documents fait partie des documents d’archives rendus made available from the collection of Public Safety disponibles par Sécurité publique Canada à ceux Canada. qui souhaitent consulter ces documents issus de sa collection. Some of these documents are available in only one official language. Translation, to be provided Certains de ces documents ne sont disponibles by Public Safety Canada, is available upon que dans une langue officielle. Sécurité publique request. Canada fournira une traduction sur demande. ________ Research Report _________ Prevalence Rates, Profile, and Outcomes for Federally Sentenced Offenders with Cognitive Deficits Ce rapport est également disponible en français. Pour en obtenir un exemplaire, veuillez vous adresser à la Direction de la recherche, Service correctionnel du Canada, 340, avenue Laurier Ouest, Ottawa (Ontario) K1A 0P9.
  • On-Line Appendix References

    On-Line Appendix References

    ON-LINE APPENDIX with the Clinical Dementia Rating scale.15 In agreement with the Neuropsychological Assessment Petersen criteria,16 participants having a CDR score of 0.5 but no At baseline, all individuals underwent a detailed neuropsycholog- dementia and a score exceeding 1.5 SDs below the age-appropri- ical assessment. The control participants were evaluated with an ate mean in any of the above tests were confirmed as to their MCI extensive neuropsychological battery, including the MMSE,1 the status. Hospital Anxiety and Depression Scale,2 and the Lawton Instru- 3 mental Activities of Daily Living. Their cognitive assessment in- REFERENCES 4 cluded the following: 1) attention (Digit Symbol Code, Trail- 1. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a prac- Making Test A5); 2) working memory (verbal: Digit Span tical method for grading the cognitive state of patients for the clini- Forward4; visuospatial: Visual Memory Span Forward4); 3) epi- cian. J Psychiatr Res 1975;12:189–98 CrossRef Medline sodic memory (verbal: RI-48 Cued Recall Test6; visual: Shapes 2. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. 7 5 Acta Psychiatr Scand 1983;67:361–70 CrossRef Medline Test ); 4) executive functions: (Trail-Making Test B, Wisconsin 3. Barberger-Gateau P, Commenges D, Gagnon M, et al. Instrumental 8 9 Card Sorting Test, Phonemic Verbal Fluency Test ); 5) language activities of daily living as a screening tool for cognitive impairment (Boston Naming Test10); 6) visual gnosis (Ghent Overlapping and dementia in elderly community dwellers. J Am Geriatr Soc 1992; Figures11); 7) praxis: ideomotor,12 reflexive,13 and constructional 40:1129–34 CrossRef Medline (Consortium to Establish a Registry for Alzheimer Disease, figure 4.